Brad Bundy is currently finishing up his Ph.D. in Chemical Engineering at Stanford University in the James Swartz Biotechnology Lab with a focus in protein production and engineering. Bundy is originally from St. George, Utah and graduated summa cum laude from Brigham Young University in 2004 with a B.S. in Chemical Engineering. After interning at Micron Technologies in Photolithography R&D, he attended Stanford University graduating with a M.S. in Chemical Engineering in 2006. While at Stanford he has served as the Teaching Assistant Training Coordinator and the Head Mentor Teaching Assistant for the Chemical Engineering Department. He is also the recipient of the Stanford Graduate Fellowship, the Micron Technology Graduate Fellowship, and the Tau Beta Pi Graduate Fellowship. Bundy’s research has focused on developing a technology for the rapid production of virus-like particles and the incorporation of non-natural amino acids into virus-like particles for site-specific bio-conjugation. This research has potential impacts in vaccine development, drug delivery and nanostructure design with Sutro Biopharma currently licensing one of the patents resulting from Bundy’s research. Bundy’s future research interests include protein engineering, metabolic engineering, and protein mega-complex characterization relating to energy, vaccine, drug delivery, and catalysis applications.
Brief Biography